s6y
Company name or ticker
Search
Clover Biopharmaceuticals, Ltd.
D/A
Exempt (Private) Offering
Filed
Tuesday, May 9, 2023
Accession number
0001104659-23-057396
Documents
primary_doc.xml
D/A
On sec.gov
Filing index
All files
Complete submission text
SGML header